Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

BUD vs STZ: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

STZ Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 6–4 Matrix Metrics)

STZ Overall Winner 6-Pillar Tally: BUD 3 – 3 STZ Matrix Metrics: BUD 4 – 6 STZ

As of Nov 16, 2026, Constellation Brands, Inc. (STZ) is the stronger overall head-to-head candidate over Anheuser-Busch INBEV SA/NV (BUD) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). BUD carries a Unified Composite Score of 34.9/100 (SELL) at $84.55 (17.4x Forward P/E, 26.7% operating margin), whereas STZ carries 41.2/100 (SELL) at $146.11 (11.8x Forward P/E, 32.8% operating margin).

  • Defensive Composite Rating Caution: Although STZ compares more favorably head-to-head, both BUD (34.9/100 SELL) and STZ (41.2/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BUD vs STZ
BUD NYSE
Anheuser-Busch INBEV SA/NV
Malt Beverages
$84.55
-0.31% 1D
Market Cap $167.3B
TTM Revenue $64.0B
Forward P/E 17.4x
Beta / 30D Vol 0.23β · 33% Vol
Unified Composite Score
34.9 / 100 SELL
Tech 36.0 Fund 35.0 Flow 50.0 Mom 6.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.0% over 20 days), RSI 57
RSI-14: 57.3 · SMA20: $83.31 · SMA50: $79.97
STZ NYSE Head-to-Head Winner
Constellation Brands, Inc.
Beverages
$146.11
+0.34% 1D
Market Cap $24.5B
TTM Revenue $9.21B
Forward P/E 11.8x
Beta / 30D Vol -0.07β · 38% Vol
Unified Composite Score
41.2 / 100 SELL
Tech 21.0 Fund 45.0 Flow 53.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.0% over 20 days), RSI 68
RSI-14: 67.9 · SMA20: $139.37 · SMA50: $128.01

6-Pillar Scorecard Institutional Category Breakdown (BUD 3 – 3 STZ)

Columns: Metric · BUD · STZ
1. Valuation Multiples STZ
Forward P/E 17.4x 11.8x
Trailing P/E 17.3x 12.9x
PEG Ratio 1.74x 1.76x
EV / Revenue 2.6x 3.8x
2. Growth & Scale BUD
Revenue Growth (YoY) +9.1% +6.1%
Earnings Growth (YoY) +52.5% +25.3%
TTM Revenue (USD) $64.0B $9.21B
Market Cap $167.3B $24.5B
3. Profitability & Quality STZ
Gross Margin 56.5% 52.8%
Operating Margin 26.7% 32.8%
Net Profit Margin 15.4% 20.9%
Return on Equity (ROE) 11.4% 24.0%
4. Balance Sheet & Cash Flow BUD
Cash Generation (TTM) $20.3B EBITDA $1.84B
Cash Flow Margin 31.7% EBITDA Mgn 20.0%
Net Cash / Leverage $7.92 Book/Sh · 11.4% ROE $10.2B Net Debt (1.20x D/E)
Dividend Yield 1.60% 2.84%
5. Options & Positioning STZ
Options Structure Phase UNCLASSIFIED SURGE
Current IV / %ile 23.6% (42nd %ile) 23.1% (19th %ile)
Put/Call OI Skew Thin ADR Chain 0.75x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markup ACCUMULATION · Markup
6. R&D & Supply-Chain Moat BUD
OpEx & R&D Intensity 29.8% of Rev ($19.1B) 20.0% of Rev ($1.84B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat High-Margin Pricing Power Moat
Supply-Chain Role Beverages - Brewers Operator Beverages - Brewers Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BUD (4) vs STZ (6)
Institutional Metric BUD STZ Criterion Row Edge
Market Capitalization
Scale
$167.3B $24.5B Larger Scale BUD
Trailing P/E Ratio
Valuation
17.3x 12.9x Lower Multiple STZ
Forward P/E Ratio
Valuation
17.4x 11.8x Lower Multiple STZ
Revenue Growth (YoY)
Growth
+9.1% +6.1% Higher Growth BUD
Operating Margin (TTM)
Profitability
26.7% 32.8% Higher Margin STZ
Net Profit Margin
Profitability
15.4% 20.9% Higher Margin STZ
Return on Equity (ROE)
Capital Efficiency
11.4% 24.0% Higher ROE STZ
52-Week Range Position
Momentum
92% ($60–$87) 61% ($111–$169) Stronger Trend BUD
Beta / 30D Volatility
Risk Regime
0.23β · 33% Vol -0.07β · 38% Vol Lower Realized Risk BUD
Unified Institutional Score
Composite Signal
34.9 / 100 (SELL) 41.2 / 100 (SELL) Higher Composite STZ
Trailing 12M Revenue (USD)
Operating Scale
$64.0B $9.21B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
56.5% 52.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.74x PEG · 2.6x EV/Rev 1.76x PEG · 3.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$20.3B EBITDA ($7.92 Book/Sh · 11.4% ROE) $1.84B ($10.2B Net Debt (1.20x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon STZ +8.87 pp
BUD: +2.37% · STZ: +11.24%
3M Horizon STZ +2.34 pp
BUD: +9.19% · STZ: +11.53%
6M Horizon BUD +4.97 pp
BUD: +3.97% · STZ: -1.0%
1Y Horizon BUD +18.26 pp
BUD: +30.92% · STZ: +12.66%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BUD vs STZ. Trailing 12-month operating profitability (BUD 26.7% vs STZ 32.8%) and valuation multiples (BUD 17.4x vs STZ 11.8x Forward P/E) are benchmarked directly in Pillar 4 below.

BUD ADR TTM Benchmark FX-Normalized USD
TTM Revenue$64.0B
Gross Margin56.5%
Op. Margin26.7%
ROE / Fwd P/E11.4% · 17.4x
STZ ADR TTM Benchmark FX-Normalized USD
TTM Revenue$9.21B
Gross Margin52.8%
Op. Margin32.8%
ROE / Fwd P/E24.0% · 11.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BUD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 23.6%
IV Percentile 42nd %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BUD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
STZ SURGE
8d in phase · OBV ACCUMULATION
Current IV 23.1%
IV Percentile 19th %ile
Put/Call OI Skew 0.75x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact STZ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BUD Moat Profile Scale & Operating Efficiency Moat
Beverages - Brewers Operator
Competes within the Beverages - Brewers value chain with $167.3B market capitalization and 26.7% operating margin.
OpEx & R&D Reinvestment 29.8% of Rev ($19.1B)
90D Engineering Disclosures 0 Published
STZ Moat Profile High-Margin Pricing Power Moat
Beverages - Brewers Operator
Competes within the Beverages - Brewers value chain with $24.5B market capitalization and 32.8% operating margin.
OpEx & R&D Reinvestment 20.0% of Rev ($1.84B)
90D Engineering Disclosures 0 Published

Investor FAQ BUD vs STZ Key Questions & Quantitative Answers

As of Nov 16, 2026, Constellation Brands, Inc. (STZ) is the stronger overall head-to-head candidate over Anheuser-Busch INBEV SA/NV (BUD) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). BUD carries a Unified Composite Score of 34.9/100 (SELL) at $84.55 (17.4x Forward P/E, 26.7% operating margin), whereas STZ carries 41.2/100 (SELL) at $146.11 (11.8x Forward P/E, 32.8% operating margin). Defensive Composite Rating Caution: Although STZ compares more favorably head-to-head, both BUD (34.9/100 SELL) and STZ (41.2/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

BUD leads the Growth & Scale pillar: BUD posts +9.1% YoY revenue growth and +52.5% YoY earnings growth on $64.0B TTM revenue (56.5% gross margin, 26.7% operating margin), compared with STZ at +6.1% YoY revenue growth and +25.3% YoY earnings growth on $9.21B TTM revenue (52.8% gross margin, 32.8% operating margin). On trailing 12-month operating scale, BUD generates $64.0B in USD-normalized revenue versus $9.21B for STZ. In operating R&D and SG&A reinvestment, BUD deploys 29.8% of Rev ($19.1B) (0 90-day corporate R&D disclosures) versus 20.0% of Rev ($1.84B) (0 disclosures) for STZ.

STZ screens cheaper on headline valuation multiples. BUD trades at 17.4x Forward P/E, 17.3x Trailing P/E, 1.74x PEG, and 2.6x EV/Revenue (31.7% EBITDA margin), whereas STZ trades at 11.8x Forward P/E, 12.9x Trailing P/E, 1.76x PEG, and 3.8x EV/Revenue (20.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BUD (11.4% ROE) versus STZ (24.0% ROE) capital efficiency.

In options market volatility and institutional positioning, BUD carries 23.6% implied volatility (42nd %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.23β · 33% Vol realized risk). By comparison, STZ carries 23.1% implied volatility (19th %ile, Compressed (<25th %ile)), a 0.75x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a SURGE options structure phase (-0.07β · 38% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.